Mink Therapeutics News and Activities

Mink Therapeutics is owned by Agenus.

Agenus is a company listed under the stock ticker AGEN (US).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 14 main executives

Most searched biographies at Mink Therapeutics

• Jennifer Buell, President and Chief Executive Officer
• Peter Behner, Director
• John Holcomb, Director

Popular executive movements at Mink Therapeutics

• Robert Kadlec, Director, has left the company  (posted on January 6 2026).
• John Holcomb has joined the company as Director  (posted on October 1 2025).
• Terese Hammond has joined the company as Head, Inflammatory and Pulmonary Diseases  (posted on September 25 2025).

Popular executive movements at Agenus

• Jose Iglesias has joined the company as Chief Medical Affairs Officer  (posted on November 19 2025).

Create your alert
to follow the executive moves at Mink Therapeutics.

Agenus has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Mink Therapeutics

• MiNK Therapeutics to Participate at BTIG Biotechnology Conference - MiNK Therapeutics
• MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update - MiNK Therapeutics
• MiNK Therapeutics Announces Virtual Annual Shareholders Meeting - MiNK Therapeutics
• MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report - MiNK Therapeutics
• MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update - MiNK Therapeutics

Social media about Mink Therapeutics

• Mink Therapeutics on Wikipedia, Google News & Yahoo Finance
• Mink Therapeutics on LinkedIn, X (Twitter) & YouTube